Judge Blasts J&J Unit For 'Tactical' Silence In Drug IP Fight
A London judge expedited a trial over the validity of Janssen Pharmaceuticals' schizophrenia drug patent on Thursday while also criticizing the Johnson & Johnson unit for being "cagey" about whether it...To view the full article, register now.
Already a subscriber? Click here to view full article